Please login or register first to view this content.
Respiratory Disorders Resource Center
Drug Monographs
Click on the subsection below to see prescribing information
NEWS & FEATURES
Global Burden of RSV Profiled in Children Aged 0 to 60 Months in 2019
Regulatory, Patent Reform Needed for Inhalers for Asthma, COPD
Loss of Smell, Taste Less Likely With Newer COVID-19 Variants
FDA Authorizes Direct-to-Consumer Test to Detect COVID-19, Influenza, and RSV
Pirfenidone Tablets Now Available for Idiopathic Pulmonary Fibrosis
CVD Risk Not Reduced With Dual Use of E-Cigarettes, Smoking
FDA Proposes Ban on Menthol Cigarettes, Flavored Cigars
Asthma, Atopy Risks Up in Offspring Born Via Infertility Treatment
Inhaled Nitric Oxide Tied to Improved P/F Ratio in COVID-19 With ARDS
Inhaled Therapy Gets Breakthrough Designation for Non-Cystic Fibrosis Bronchiectasis
Acute Upper Airway Disease Up in Children During Omicron Surge
New Law Allows FDA to Police E-Cigarettes Made With Synthetic Nicotine
Efzofitimod Granted Orphan Drug Status for Systemic Sclerosis
Sabizabulin Cuts COVID-19 Death; Trial Stopped Early Due to Efficacy
Tocilizumab Gets Priority Review for Treatment of Hospitalized COVID-19 Patients
March 2022: Drug Pipeline Updates
RSV Vaccine Candidate for Older Adults Gets Breakthrough Therapy Designation
Losartan Does Not Reduce Lung Injury in Hospitalized COVID-19 Patients
